LumaBridge (formerly known as Cancer Insight), a San Antonio, TX-based oncology-focused clinical research organization (CRO), received a majority growth investment from global investor Summit Partners.
The amount of the deal was not disclosed. Mark deLaar, a managing director at Summit Partners who has joined the LumaBridge board of directors.
The funding will help the company continue to build on its work offering clinical trial solutions to support emerging biopharma companies that are working to develop life-changing immuno-oncology treatments.
Founded in 2014 by veterans Dr. George Peoples and Dan Hargrove, LumaBridge serves as a strategic partner to emerging biopharma and biotech companies, offering full outsourced clinical trial support across the entire timeline of clinical development. It offers comprehensive CRO services, including consultation on clinical development strategy, as well as special capabilities in military research.
Over the 8 years since its founding, LumaBridge has supported a substantial number of trials and projects for over 30 clients.
FinSMEs
23/08/2022